AVNR

Avanir Pharmaceuticals, Inc. Press Releases

$16.91
*  
0.01
0.06%
Get AVNR Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading AVNR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)
12/9/2014 8:30:00 AM - PR Newswire
▼-0.29 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Law Offices of Marc S. Henzel Announces Securities Class Action Periods
12/8/2014 9:11:00 AM - PR Newswire


Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call
12/5/2014 4:01:00 PM - PR Newswire
▼-0.47 % Price Change since this news event. The Volume Ratio is 0.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey''s General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.
12/4/2014 1:21:00 PM - PR Newswire


Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.
12/4/2014 1:21:00 PM - PR Newswire
▼-0.12 % Price Change since this news event. The Volume Ratio is 1.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/4/2014 11:39:00 AM - Business Wire
▼-0.06 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Avanir Pharmaceuticals, Inc. May Not Be In the Best Interests of Its Investors
12/4/2014 11:30:00 AM - PR Newswire
▼-0.06 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover
12/4/2014 10:33:00 AM - PR Newswire
▼-0.06 % Price Change since this news event. The Volume Ratio is 1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AVANIR PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Avanir Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Otsuka Pharmaceutical Co., Ltd. - AVNR
12/3/2014 7:30:00 PM - PR Newswire
▼-0.06 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ryan & Maniskas, LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
12/3/2014 10:33:00 AM - PR Newswire


Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
12/2/2014 8:00:00 PM - PR Newswire


Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
12/2/2014 8:00:00 PM - PR Newswire
unchange Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd.
12/2/2014 12:24:00 PM - Business Wire
▼-0.06 % Price Change since this news event. The Volume Ratio is 15.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Block & Leviton LLP Investigates Avanir Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Otsuka Pharmaceutical Co., Ltd.
12/2/2014 10:49:00 AM - PR Newswire
▼-0.12 % Price Change since this news event. The Volume Ratio is 17.17.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/2/2014 10:32:00 AM - PR Newswire
▼-0.18 % Price Change since this news event. The Volume Ratio is 17.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
12/2/2014 3:35:00 AM - PR Newswire
▲12.73 % Price Change since this news event. The Volume Ratio is 34.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals Announces Date of Fiscal 2014 Fourth Quarter Financial Results and Conference Call
12/1/2014 4:01:00 PM - GlobeNewswire


Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA
11/26/2014 4:54:00 PM - PR Newswire


Avanir Pharmaceuticals to Participate in Two Conferences in December
11/20/2014 9:00:00 AM - PR Newswire


Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine
11/7/2014 8:30:00 AM - PR Newswire
▲28.40 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache"
10/30/2014 4:01:00 PM - PR Newswire
▲28.11 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease at the American Neurological Association Meeting
10/13/2014 4:26:00 PM - PR Newswire
▲43.31 % Price Change since this news event. The Volume Ratio is 2.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014
10/8/2014 4:15:00 PM - PR Newswire
▲44.04 % Price Change since this news event. The Volume Ratio is 0.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease
10/8/2014 8:30:00 AM - PR Newswire


Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
9/29/2014 9:15:00 AM - PR Newswire


    • << first
    • < previous
    • 1
    • next >
    • last >>